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doi:10.1016/j.jmii.2011.12.023Background/Purpose: Tuberculosis (TB) is endemic in Taiwan and usually affects the lung,
spinal TB accounting for 1e3% of all TB infections. The manifestations of spinal TB are
different from those of pulmonary TB. The purpose of this study was to define the epidemio-
logical molecular types of mycobacterial strains causing spinal TB.
Methods: We retrospectively reviewed the medical charts of adult patients diagnosed with
spinal TB from January 1998 to December 2007. Patients with positive culture results and/or
pathological findings characteristic of TB were enrolled in this study. Spoligotyping was per-
formed to type the Mycobacterium tuberculosis isolates.
Results: A total of 38 patients with spinal TB were identified. Their mean age was 68 years, and
their median duration of symptoms was 60 days (range 3e720 days). The lumbar and thoracic
spine accounted for 76% of the sites involved. Thirteen specimens (from seven male and six
female patients) were available for typing. Spoligotyping of these 13 specimens revealed three
Beijing (23%) and 10 non-Beijing types (77%). The non-Beijing types included two EAI2 Manilla
(15%), two H3 (15%), two unclassified (15%), and one each of BOVIS1, U, T2, and orphan type.
No significant predominant strain was found in this study, and no drug-resistant Beijing strains
were identified.of Laboratory Medicine, China Medical University Hospital, 2 Yuh-Der Road, Taichung City, Taiwan.
com, d17405@mail.cmuh.org.tw (J.-J. Lu).
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20 C.-Y. Weng et al.Conclusion: TB spondylitis was found to occur in older patients. Spoligotyping results showed
that most of the TB spondylitis cases were caused by non-Beijing type Mycobacterium
tuberculosis.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Taiwan implemented its National Tuberculosis Program
more than 50 years ago, and the prevalence and mortality
rate of tuberculosis (TB) has gradually declined since then.
However, TB remains a leading notified infectious disease in
Taiwan. In 2007, the TB notification and mortality rates
were 63.2 and 3.4 per 100,000 people, respectively.1 Most
cases of TB were pulmonary, extrapulmonary cases
accounting for 6% of the total notified cases of TB. Bone and
joint TB was rare, accounting for only 1% of the cases
notified. The diagnosis of extrapulmonary TB is more diffi-
cult than that of pulmonary TB because it mainly depends
on tissue culture and pathology.
TB spondylitis is an indolent and progressive neurological
disease.2 Unlike pulmonary TB, spinal TB rarely exhibits
constitutional symptoms such as fever, body weight loss, or
night sweating.3,4 This atypical presentation of TB spon-
dylitis raises the question of whether the causative TB
strains are different from those of pulmonary TB.
The development of various TB typing methods has
enabled epidemiological studies of TB. Using spoligotyping,
Jou et al. found that 44.4% of Mycobacterium tuberculosis
(MTB) isolates from different regions in Taiwan were of
Beijing family genotypes. The proportion of the Beijing
genotype isolates was the highest in patients under the age
of 24 years (61.5%).5 However, there have been no studies
using spoligotyping to investigate TB spondylitis.
Spoligotyping is a polymerase chain reaction (PCR)-
based method used to analyze the strain polymorphisms in
the MTB short direct repeat chromosomal region. This
region consists of 36 identical 36 bp direct repeats inter-
spersed by 35e41 bp nonrepetitive spacer sequences.6 The
purpose of this study was to use spoligotyping to determine
the epidemiological molecular types of MTB isolates causing
TB spondylitis.Materials and methods
Patients
The basic data and clinical presentation of all patients
diagnosed with spinal TB at the China Medical University
Hospital, Taichung, Taiwan from January 1998 to December
2007 were collected by reviewing medical charts. Spinal TB
was diagnosed based on the following criteria: (1) the
presence of osteomyelitis in one or more vertebral
segments, (2) MTB isolated from an abscess or tissue biopsy
specimen, and (3) histology of a tissue specimen demon-
strating caseating granuloma or granulomatous inflamma-
tion with a positive acid-fast bacillus smear.3 Patients whofulfilled criterion (1) plus criterion (2) or (3) were included
in this study. Probable cases, not confirmed microbiologi-
cally or pathologically but responding to anti-TB therapy,
were excluded. All patients enrolled in this study were
adult (18 years old). The study was approved by the
Institutional Review Board of China Medical University
Hospital, Taichung, Taiwan (DMR100-IRB-016).
Mycobacterial strains and genomic DNA
Various MTB culture and identification systems were used
during the study period. The first was the BACTEC MGIT
960 system (Becton Dickinson, Sparks, Maryland, USA).
Clinical specimens were processed, and the centrifuged
sediment was inoculated onto Lo¨wensteineJensen medium
(BBL; Becton Dickinson, Sparks, MD, USA) and Middlebrook
7H9 broth (BBL; Becton Dickinson). The cultures were
incubated at 35C in 5% carbon dioxide for up to 8 weeks.
Identification of MTB was based on colony morphology and
biochemistry reactions (nitrate reduction and niacin test).
In 2004, the traditional biochemistry methods for MTB
identification and drug susceptibility were replaced by the
Protec ET system (Becton Dickinson).7 MTB genomic DNA
was extracted as previously described.8
Multiplex PCR for typing MTB
All MTB were stored bacterial specimens from positive MTB
cultures, which is a standard method for the clinical diag-
nosis of TB. It has been determined that the region span-
ning genes Rv2816 to Rv2819 and part of Rv2820 is deleted
in the genome of all Beijing strains of MTB.9 Based on this
information, three sets of PCR primers were used to
distinguish between Beijing and non-Beijing strains.10
The first set of primers, BjF (CTCGGCAGCTTCCTCGAT)
and BjR (CGAACTCGAGGCTGCCTACTAC), produced a 129 bp
PCR product containing the 30 end of IS6110 and the 50 end
of the Rv2820 gene from the Beijing strains of MTB.11 The
second set of PCR primers, nBjF(AAGCATTCCCTTGA-
CAGTCGAA) 1 and nBjR (GGCGCATGACTCGAAAG AAG),
produced a 95 bp PCR product from the Rv2819 gene of non-
Beijing strains of MTB. The third primer set, IS59
(GCGCCAGGCGCAGGTCGATGC) and IS60 (GATCAGC-
GATCGTGGTCCTGC), amplified a 523 bp PCR product from
IS6110 that is present in all MTB isolates; this reaction
served as the internal PCR control.
Multiplex PCRs with these three sets of primers were
performed for all specimens. A Beijing strain of MTB was
expected to produce two amplicons: the 523 bp internal
control product and the 129 bp product. A non-Beijing
strain was expected to produce the 523 bp and the 95 bp
products.
Table 1 Genotypes and drug resistance patterns of
Mycobacterium tuberculosis isolates from patients with
culture-confirmed tuberculosis (TB)
Genotype
family
Number
of isolates
Resistant to
any first-line
anti-TB drug
Sensitive to all
four first-line
anti-TB drugs
Beijing 3 0 3
Non-Beijing 10
EAI2 2 0 2
H3 2 2 0
Unknown 2 0 2
BOVIS1 1 1 0
U 1 0 1
T2 1 0 1
Orphan 1 1 0
Total 13 4 9
First-line anti-TB drugs were rifampin, isoniazid, ethambutol,
and streptomycin.
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Spoligotyping was performed according to the manufac-
turer’s instructions (Isogen Bioscience B.V., Maarssen, The
Netherlands). The positive or negative hybridization result
was represented by binary codes n and o, respectively, and
analyzed using the Microsoft Office Excel 2007 (Microsoft
Taiwan Corporation, Taipei, Taiwan) to group and order the
hybridization patterns. Spoligotypes common to more than
one strain were designated as shared types (ST) and assigned
a shared international type number according to the updated
version of the international spoligotype database SpolDB4.
Statistical analysis
Statistical Package for the Social Science (version 13.0;
SPSS, Chicago, IL, USA) was used for statistical analysis.
Data were presented as mean  standard deviation.
Results
During the 10-year period of the study, 3240 cases of
pulmonary TB and 404 of extrapulmonary TB were diag-
nosed. Among the extrapulmonary cases, 38 were spinal TB.
The median age of these 38 patients with spinal TB was
72 years (interquartile range 18 years). The majority of
patients (65.8%) were 70 years or older, and three were
younger than 50 years old.
The median duration of symptoms before diagnosis was
60 days (range 3e720 days). At the time of diagnosis, nine
of the 38 patients (24%) had constitutional symptoms. Back
pain was the most common clinical complaint (38 patients,
100%), followed by weakness (20 patients, 53%) and
numbness (10 patients, 26%).
Thirty-four of the 38 patients were followed up after
completion of anti-TB treatment. Most patients recovered
without any motor or sensory deficit in their daily activities,
and no relapse was reported during the period of follow-up
(mean duration 10.6 months). One patient was lost to
follow-up, and three patients died of their comorbidities
during the treatment period.
Thirteen MTB isolates from 13 of the 38 cases of spinal TB
were available for further study. The results of drug
susceptibility assays (Table 1) showed that nine (69.2%) of
these isolates were sensitive to all four of the first-line anti-
TB drugs (rifampin, isoniazid, ethambutol, and strepto-
mycin), and four (30.7%) were resistant to at least one drug.
No multidrug-resistant strain was detected. The median
treatment duration was 11 months (range 6e32 months).
Table 2 shows the spoligotypes of the 13 MTB isolates. Of
these, three (23%) were of Beijing type. The others included
two (15%) EAI2 Manilla strains, two (15%) H3, two (15%)
unclassified strains, andoneeachofBOVIS1,U,T2,andorphan
type. The multiplex PCR results showed three Beijing and 10
non-Beijing types, consistent with those of the spoligotyping.
Discussion
The Beijing genotype family of MTB isolates is well known
to have a distinct and highly conserved genetic signature.12It is present worldwide and is more prevalent in certain
areas, such as Asia13,14 and Russia.15 Drug-resistant Beijing
family genotype strains and their transmissions have been
documented.16e18 Many MTB genotyping studies have been
reported.12,19e21 Most of these examined isolates from all
infected sites as a whole, while some focused on pulmonary
isolates. In this study, we investigated and genotyped
isolates from patients with TB spondylitis in a medical
center located in central Taiwan.
Spinal TB was first described in 1782 by Sir Percival
Pott.22 It accounts for 50% of skeletal TB,22,23 and 1e3% of
all TB cases.24e26 In our institution, spinal TB represents 1%
(38/3644) of all TB cases. Unlike those in the other
reports,27,28 the population of our subjects were older, with
65.8% being aged 70 years or older, probably due to the
longer life expectancy in Taiwan.28
Similar to other studies,3,28 back pain was most common
for spinal TB, followed by weakness and numbness. Unlike
pulmonary TB, spinal TB seldom exhibits constitutional
symptoms such as fever, body weight loss or night
sweating,3 and this atypical feature was also observed in
our study. The inability of MTB to grow in a low-oxygen
environment such as the spine may be the reason for the
atypical presentation of spinal TB. Considerable variation in
the duration of symptoms was also observed in the present
study, and this may be due to the insidious clinical course
and nonspecific manifestations of spinal TB.3,29
The genetic heterogeneity of MTB isolates may influence
their transmissibility and virulence.30e32 The Beijing strain
is rapidly increasing in prevalence.33 It is more readily
aerosolized and more infectious, and the infection prog-
resses more quickly. Since spinal TB progresses slowly with
more subtle clinical symptoms, it is possible that the
causative strains are different from those of pulmonary TB,
in which the Beijing strain predominates, even though only
13 MTB isolates underwent genotyping in this study.
In this study, one non-Beijing MTB isolate belonged to
genotype OBVIS1. Because the diagnosis of MTB in our
microbiology laboratory was ascertained using BD Protect,
we were unable to differentiate M. bovis from
Table 2 Spoligotypes of the 13 Mycobacterium tuberculosis isolates
Sample
number
Hybridization results of spoligotyping Type
1 --,----------------,,-------,,,,-,------
---
(ST19,EAI2_
MANILLA)
2 -------------,,,,,,,,,,,----------------
---
(Unknown)
3 --,----------------,,-------,,,,-,-----,
---
(ST849,H3)
4 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,------
---
Beijing (ST1)
5 ----------------------,-------,-,,,,---,
---
(Unknown)
6 ----------------------------------------
---
(ST523,U)
7 ------------------------------,-,,,,----
---
(ST50,H3)
8 --,----------------,,-------,,,,-,------
---
(ST19,EAI2_
MANILLA)
9 --,--,--,------,----,-----------------,,
,,,
(ST684,BOVIS1)
10 --------------------------------,,,,---,
---
(ST52,T2)
11 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,------
---
Beijing (ST1)
12 ,,,,,,,,,,,,,,,,,,,,,,,,---------------,
,--
(Orphan)
13 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,------
---
Beijing (ST1)
22 C.-Y. Weng et al.M. tuberculosis complex. However, the spoligotyping
profiles of this isolate were typical of M. bovis with the
absence of spacers 3, 6,9, 16, 21, and 39e43, which has
also been found with human TB in Taiwan.34 Mycobacterium
bovis was highly suspected in this case of a 74eyear-old
Aboriginal female with degenerative scoliosis of the lumbar
spine and bilateral lower limb weakness for about 2 weeks
before admission. There was no history of drinking unpas-
teurized milk, eating raw meat, or close contact with
infected animals.
In summary, we found that the MTB isolates from spinal
TB were different from those from pulmonary TB. Non-
Beijing strains were found to be predominant in this patient
group. Since the sample size of this study was relatively
small, additional studies with more enrollments are needed
to confirm our results.
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